In last trading session, Leap Therapeutics Inc (NASDAQ:LPTX) saw 0.3 million shares changing hands with its beta currently measuring 0.22. Company’s recent per share price level of $3.06 trading at -$0.32 or -9.60% at ring of the bell on the day assigns it a market valuation of $117.26M. That closing price of LPTX’s stock is at a discount of -56.54% from its 52-week high price of $4.79 and is indicating a premium of 45.1% from its 52-week low price of $1.68. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.24 million shares which gives us an average trading volume of 384.87K if we extend that period to 3-months.
For Leap Therapeutics Inc (LPTX), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.25. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Leap Therapeutics Inc (NASDAQ:LPTX) trade information
Upright in the red during last session for losing -9.60%, in the last five days LPTX remained trading in the red while hitting it’s week-highest on Tuesday, 01/07/25 when the stock touched $3.06 price level, adding 14.53% to its value on the day. Leap Therapeutics Inc’s shares saw a change of 6.43% in year-to-date performance and have moved -4.97% in past 5-day. Leap Therapeutics Inc (NASDAQ:LPTX) showed a performance of -4.38% in past 30-days. Number of shares sold short was 1.01 million shares which calculate 2.68 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 5.5 to the stock, which implies a rise of 44.36% to its current value. Analysts have been projecting 5.5 as a low price target for the stock while placing it at a high target of 5.5. It follows that stock’s current price would drop -79.74% in reaching the projected high whereas dropping to the targeted low would mean a loss of -79.74% for stock’s current value.
Leap Therapeutics Inc (LPTX) estimates and forecasts
Statistics highlight that Leap Therapeutics Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company added 46.41% of value to its shares in past 6 months, showing an annual growth rate of 53.77% while that of industry is 16.50. Apart from that, the company came raising its revenue forecast for fiscal year 2025.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 28.36% during past 5 years.
Leap Therapeutics Inc (NASDAQ:LPTX)’s Major holders
Insiders are in possession of 17.29% of company’s total shares while institution are holding 40.30 percent of that, with stock having share float percentage of 48.73%. Investors also watch the number of corporate investors in a company very closely, which is 40.30% institutions for Leap Therapeutics Inc that are currently holding shares of the company.
On the other hand, Simplify Exchange Traded Fds-Health Care ETF and Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024 , the former fund manager was holding 1.06 shares of worth $3.23 million or 2.76% of the total outstanding shares. The later fund manager was in possession of 754.74 shares on Sep 30, 2024 , making its stake of worth around $2.31 million in the company or a holder of 1.97% of company’s stock.
